(19)
(11) EP 2 994 120 A2

(12)

(88) Date of publication A3:
31.12.2014

(43) Date of publication:
16.03.2016 Bulletin 2016/11

(21) Application number: 14729541.4

(22) Date of filing: 05.05.2014
(51) International Patent Classification (IPC): 
A61K 31/137(2006.01)
A61K 31/4174(2006.01)
A61K 31/165(2006.01)
A61P 17/02(2006.01)
A61K 31/4164(2006.01)
A61K 31/498(2006.01)
A61K 9/00(2006.01)
(86) International application number:
PCT/US2014/036778
(87) International publication number:
WO 2014/182610 (13.11.2014 Gazette 2014/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 06.05.2013 US 201361819927 P

(71) Applicant: ALLERGAN, INC.
Irvine, CA 92612 (US)

(72) Inventors:
  • GIL, Daniel W.
    Corona Del Mar, California 92625 (US)
  • ANDREWS-JONES, Lydia L.
    Lake Forest, California 92630 (US)
  • HSIA, Edward C.
    Irvine, California 92620 (US)
  • TIAN, Mingting
    Irvine, California 92602 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA